<DOC>
	<DOCNO>NCT00212719</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety ONO-5920 patient involutional osteoporosis .</brief_summary>
	<brief_title>Controlled Study ONO-5920 Patients With Involutional Osteoporosis Japan</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Diphosphonates</mesh_term>
	<criteria>1 . A diagnosis accordance Criteria Diagnosis Primary Osteoporosis . 2 . Other inclusion criterion specify study protocol . 1 . Patients secondary osteoporosis another condition present low bone mass . 2 . Patients finding affect measurement lumbar spinal bone mineral density DXA 3 . Patients administered bisphosphonate derivative . 4 . Other exclusion criterion specify study protocol .</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>ONO-5920 , osteoporosis , bisphosphonate</keyword>
</DOC>